It has been demonstrated that the activation of NF-κB was caused by mutations in multiple genes, one of which was TNF receptor-associated factor 5 (TRAF5), and the deregulation of TRAF5 may promote the malignant transformation of DLBCL [8]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.